HealthQuill Just Evotec Biologics
Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for the development of a monoclonal antibody-based product prototype to target orthopoxviruses.
Drugs Health Pharma

Germany’s Evotec wins $74 million US contract to make drug to fight orthopoxviruses

HQ Team July 5, 2023: Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for.

Read More
X